People · Operator
Named in public records as an officer, director or promoter · active 2009–2017 · Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Semma Therapeutics, Inc. | — | Biotechnology | Series D+ | $129.3M | $4.7B | 2015 |
| iWalk, Inc. | — | Other Health Care | Series B | $74.5M | $377.9M | 2009 |
William Sahlman at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside William Sahlman on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Todd Foley | 1 | 12 |
| John Simon | 1 | 11 |
| William F. Doyle | 1 | 8 |
| Geoff Pardo | 1 | 6 |
| Paul Flanagan | 1 | 6 |
| STEPHEN KNIGHT | 1 | 6 |
| Kevin Raidy | 1 | 4 |
| Kevin Connors | 1 | 4 |
| Timothy McCarthy | 1 | 3 |
| Mitchell Finer | 1 | 3 |
| Daniel Auerbach | 1 | 3 |
| Michael Ellenbogen | 1 | 3 |
| Robert Millman | 1 | 3 |
| Charles Carignan | 1 | 3 |
| Mark Fishman | 1 | 3 |
| Elizabeth Stoner | 1 | 2 |
| Ian J. Vawter | 1 | 2 |
| Jim Scopa | 1 | 2 |
| Bastiano Sanna | 1 | 2 |
| Mitch Finer | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.